ESS
70
-4
LEG
17
-5
SE
41
-5
BWA
40
-4
RIG
26
-2
KEY
43
-3
V
62
-4
PNW
49
3
KMI
61
-2
CPB
35
-5
XRX
45
-4
HP
40
3
EQIX
45
-2
MMC
53
-5
GOOG
87
2
XYL
41
-4
CNX
48
-4
WMT
76
-6
VRSN
53
-2
MSFT
67
2
ESS
70
-4
LEG
17
-5
SE
41
-5
BWA
40
-4
RIG
26
-2
KEY
43
-3
V
62
-4
PNW
49
3
KMI
61
-2
CPB
35
-5
XRX
45
-4
HP
40
3
EQIX
45
-2
MMC
53
-5
GOOG
87
2
XYL
41
-4
CNX
48
-4
WMT
76
-6
VRSN
53
-2
MSFT
67
2
Financhill
Back

The Arena Group Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
31

AREN
The Arena Group Holdings

Last Price:
0.82
Seasonality Move:
0.47%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
31
The Arena Group Holdings (AREN) is a Sell

Is The Arena Group Holdings a Buy, Sell or Hold?

  • The current The Arena Group Holdings [AREN] share price is $0.80. The Score for AREN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • AREN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AREN Stock Price Chart

What is The Arena Group Holdings's stock price today?

  • The The Arena Group Holdings share price today is $0.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AREN is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

AREN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 45.32 Sell
Chaikin Money Flow: 1553 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.81 - 0.89) Sell
Bollinger Bands (100): (0.69 - 1.49) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

AREN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.84 Sell
20-day SMA: 0.86 Sell
50-day SMA: 0.8 Sell
200-day SMA: 2.08 Sell
8-day EMA: 0.83 Sell
20-day EMA: 0.84 Sell
50-day EMA: 0.9 Sell
200-day EMA: 2.09 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

The Arena Group Holdings Earnings Growth & AREN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.59 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

The Arena Group Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):